Literature DB >> 26602880

[Dosing adjustment and renal function: Which equation(s)?].

Pierre Delanaye1, Martin Flamant2, Étienne Cavalier3, Fabrice Guerber4, Thomas Vallotton5, Olivier Moranne6, Hans Pottel7, Jean-Jacques Boffa8, Christophe Mariat9.   

Abstract

While the CKD-EPI (for Chronic Kidney Disease Epidemiology) equation is now implemented worldwide, utilization of the Cockcroft formula is still advocated by some physicians for drug dosage adjustment. Justifications for this recommendation are that the Cockcroft formula was preferentially used to determine dose adjustments according to renal function during the development of many drugs, better predicts drugs-related adverse events and decreases the risk of drug overexposure in the elderly. In this opinion paper, we discuss the weaknesses of the rationale supporting the Cockcroft formula and endorse the French HAS (Haute Autorité de santé) recommendation regarding the preferential use of the CKD-EPI equation. When glomerular filtration rate (GFR) is estimated in order to adjust drug dosage, the CKD-EPI value should be re-expressed for the individual body surface area (BSA). Given the difficulty to accurately estimate GFR in the elderly and in individuals with extra-normal BSA, we recommend to prescribe in priority monitorable drugs in those populations or to determine their "true" GFR using a direct measurement method.
Copyright © 2015 Association Société de néphrologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Adaptation posologique; CKD-EPI; Cockcroft; Dosage adjustment

Mesh:

Year:  2015        PMID: 26602880     DOI: 10.1016/j.nephro.2015.07.472

Source DB:  PubMed          Journal:  Nephrol Ther        ISSN: 1769-7255            Impact factor:   0.722


  2 in total

1.  Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort.

Authors:  Solène M Laville; Marie Metzger; Bénédicte Stengel; Christian Jacquelinet; Christian Combe; Denis Fouque; Maurice Laville; Luc Frimat; Carole Ayav; Elodie Speyer; Bruce M Robinson; Ziad A Massy; Sophie Liabeuf
Journal:  Br J Clin Pharmacol       Date:  2018-09-24       Impact factor: 4.335

2.  Defining explicit definitions of potentially inappropriate prescriptions for antidiabetic drugs in patients with type 2 diabetes: A systematic review.

Authors:  Erwin Gerard; Paul Quindroit; Madleen Lemaitre; Laurine Robert; Sophie Gautier; Bertrand Decaudin; Anne Vambergue; Jean-Baptiste Beuscart
Journal:  PLoS One       Date:  2022-09-12       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.